Valuation DexCom, Inc. Mexican S.E.
Stocks
DXCM *
US2521311074
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,241.72 MXN | 0.00% |
|
0.00% | +2.37% |
| 06-12 | FDA clears first over-the-counter glucose monitor for children | RE |
| 06-11 | Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction | RE |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 29,083 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 12.35% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 28,714 | 27,836 | 26,729 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 9.56% | -3.06% | -3.97% |
| P/E Ratio | 346x | 138x | 95.5x | 54.8x | 31.8x | 30.8x | 25.8x | 21.5x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.2x | 10.9x | 7.85x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.3x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.57x | 4.99x | 4.46x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.5x | 4.77x | 4.1x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 17.5x | 14.6x | 12.1x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 23.7x | 19.4x | 15.5x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 28.9x | 22.4x | 17.6x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.46% | 4.46% | 5.67% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,830 | 6,525 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,637 | 1,909 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,437 | 1,721 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -369.5 | -1,248 | -2,354 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 75.37 | 75.37 | 75.37 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.18x | 3.29x | 12.35x | 2.89% | 154B | |
| 20.16x | 3.48x | 12.52x | 3.56% | 103B | |
| 36x | 8.9x | 23.96x | 1.07% | 55.22B | |
| 14.84x | 0.18x | 11.13x | 0.84% | 54.8B | |
| 36.44x | 2.93x | 10.05x | 2.63% | 40.3B | |
| 35.05x | 1.3x | 11.46x | 0.22% | 30.96B | |
| 39.05x | 6.75x | 24.36x | 0.27% | 23.23B | |
| 23.72x | 3.03x | 12.36x | 1.36% | 20.25B | |
| 23.02x | 3.32x | 11.92x | 1.27% | 20.23B | |
| Average | 27.83x | 3.69x | 14.46x | 1.57% | 55.73B | |
| Weighted average by Cap. | 25.30x | 3.61x | 13.83x | 2.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DXCM * Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
